Braden Michael Leonard, 10% Owner at Talis Biomedical Corp (TLIS), bought 151 shares at $4.25 ($642) on 2024-08-30, disclosed to the SEC on 2024-09-04.
Open-market purchase of $642 TLIS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |